MedTrace Logo

Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate)

NCT02530541 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2021-04-30

Study results available
· View outcomes & findings →

Summary

Pilot study to evaluate and compare activity of preoperative preparation with comparator

Conditions

  • Healthy

Interventions

DRUG

CHG

Varied application times

Sponsors & Collaborators

  • Medline Industries

    lead INDUSTRY

Principal Investigators

  • Esther Campbell · Bioscience Labs

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-07-31
Completion
2015-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02530541 on ClinicalTrials.gov